Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life

NCT02701088 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Anal Canal Cancer

Interventions

DRUG: 5Fluorouracile and Mitomycin-C
RADIATION: Simultaneously integrated boost of intensity modulated radiation therapy (SIB-IMRT) by tomotherapy

Sponsor

Centre Francois Baclesse

Collaborators

[object Object]